ESR1 and breast cancer: Regarding estrogenicity via ERα of the various PBDE congeners, two studies were based on estrogen response element (ERE)-luciferase assay using a human T47D breast cancer cell line (ER-CALUX; Legler et al. 1999) for estrogenic activity testing.